MAPT and Alzheimer disease: Since phosphorylation of tau is attenuated by the glycogen synthase kinase 3 inhibitor, this provides preliminary evidence for a beneficiary role of H. pylori eradication in AD and the need for verification by large-scale clinical trials [76].